An FDA advisory committee on Thursday voted in favor of a respiratory syncytial virus vaccine that would be administered to pregnant people to protect their infants.
A committee of experts voted in favor of a new shot administered to pregnant women, one in a series of new ways to arm the very young against a life-threatening virus.